AFYA Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 29, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Mar 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AFYA SEC filings page.
Afya Limited (AFYA) reported $675.1M in revenue for fiscal year 2025, up 26.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Afya Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Afya Limited has an operating margin of 32.8%, meaning the company retains $33 of operating profit per $100 of revenue. This strong profitability earns a score of 92/100, reflecting efficient cost management and pricing power. This is up from 30.6% the prior year.
Afya Limited's revenue surged 26.3% year-over-year to $675.1M, reflecting rapid business expansion. This strong growth earns a score of 56/100.
Afya Limited has a moderate D/E ratio of 0.41. This balance of debt and equity financing earns a leverage score of 59/100.
Afya Limited's current ratio of 2.20 indicates adequate short-term liquidity, earning a score of 64/100. The company can meet its near-term obligations, though with limited headroom.
Afya Limited converts 36.9% of revenue into free cash flow ($249.3M). This strong cash generation earns a score of 96/100.
Afya Limited earns a strong 15.5% return on equity (ROE), meaning it generates $16 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 78/100. This is up from 14.8% the prior year.
Afya Limited scores 2.01, placing it in the grey zone between 1.81 and 2.99. The largest contribution to the score comes from a market capitalization of $899.8M against total liabilities of $815.5M. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Afya Limited passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Afya Limited generates $2.04 in operating cash flow ($279.6M OCF vs $137.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Afya Limited earns $2.16 in operating income for every $1 of interest expense ($221.5M vs $102.4M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Afya Limited generated $675.1M in revenue in fiscal year 2025. This represents an increase of 26.3% from the prior year.
Afya Limited's EBITDA was $289.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 33.1% from the prior year.
Afya Limited reported $137.4M in net income in fiscal year 2025. This represents an increase of 34.5% from the prior year.
Afya Limited earned $1.50 per diluted share (EPS) in fiscal year 2025. This represents an increase of 34.3% from the prior year.
Cash & Balance Sheet
Afya Limited generated $249.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 19.0% from the prior year.
Afya Limited held $205.5M in cash against $364.0M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Afya Limited's gross margin was 64.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.2 percentage points from the prior year.
Afya Limited's operating margin was 32.8% in fiscal year 2025, reflecting core business profitability. This is up 2.2 percentage points from the prior year.
Afya Limited's net profit margin was 20.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.2 percentage points from the prior year.
Afya Limited's ROE was 15.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.7 percentage points from the prior year.
Capital Allocation
Afya Limited invested $30.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 36.9% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
AFYA Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $675.1M+26.3% | $534.3M-9.8% | $592.7M+34.5% | $440.6M+42.9% | $308.4M+33.3% | $231.3M+23.8% | $186.8M+117.0% | $86.1M+32.0% | $65.2M |
| Cost of Revenue | $239.9M+22.0% | $196.6M-14.1% | $228.7M+40.7% | $162.6M+39.0% | $117.0M+39.8% | $83.7Mn/m | -$76.8M-277.4% | $43.3M+15.6% | $37.5M |
| Gross Profit | $435.2M+28.8% | $337.8M-7.2% | $364.0M+30.9% | $278.0M+45.2% | $191.4M+29.7% | $147.6M+34.3% | $109.9M+157.1% | $42.7M+54.0% | $27.8M |
| Operating Income | $221.5M+35.3% | $163.7M+3.5% | $158.1M+25.8% | $125.6M+58.9% | $79.1M+13.0% | $70.0M+37.0% | $51.1M+105.5% | $24.9M+66.8% | $14.9M |
| EBITDA | $289.7M+33.1% | $217.6M-0.1% | $217.8M+32.3% | $164.6M+54.2% | $106.7M+17.4% | $90.9M+31.2% | $69.3M+154.7% | $27.2M+68.8% | $16.1M |
| Interest Expense | $102.4M+38.1% | $74.2M-21.3% | $94.3M+42.5% | $66.2M+51.4% | $43.7M+789.2% | $4.9M-17.6% | $6.0M+864.0% | $620K+96.9% | $315K |
| Income Tax | -$3.3M-174.4% | $4.4M-10.8% | $5.0M-26.2% | $6.7M+20.7% | $5.6M+7.3% | $5.2M+47.8% | $3.5M+243.2% | $1.0M+36.2% | $755K |
| Net Income | $137.4M+34.5% | $102.1M+28.3% | $79.6M+12.7% | $70.7M+76.4% | $40.1M-28.8% | $56.2M+46.8% | $38.3M+72.1% | $22.3M+62.4% | $13.7M |
| EPS (Basic) | $1.52+34.0% | $1.13+27.9% | $0.89+13.2% | $0.78+82.7% | $0.43-29.3% | $0.61+20.1% | $0.51 | $0.47+11.4% | $0.43 |
| EPS (Diluted) | $1.50+34.3% | $1.12+27.3% | $0.88+12.9% | $0.78+83.3% | $0.43-29.2% | $0.60+19.5% | $0.50 | $0.47+9.6% | $0.43 |
| Diluted Shares (Avg) | 91M+0.1% | 91M+0.7% | 91M-0.1% | 91M-3.7% | 94M+0.5% | 94M+22.9% | 76M | 48M+48.4% | 32M |
Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses.
AFYA Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.7B+19.7% | $1.4B-8.7% | $1.6B+14.8% | $1.4B+17.8% | $1.2B+25.3% | $922.9M+27.4% | $724.7M+206.2% | $236.7M | N/A |
| Current Assets | $354.6M+37.9% | $257.1M+3.6% | $248.0M-19.9% | $309.8M+43.1% | $216.5M-20.0% | $270.6M-2.2% | $276.6M+704.1% | $34.4M | N/A |
| Cash & Equivalents | $205.5M+39.5% | $147.3M+29.3% | $114.0M-44.9% | $206.8M+54.0% | $134.3M-33.3% | $201.2M-14.3% | $234.7M+1362.7% | $16.0M+108.5% | $7.7M |
| Inventory | N/A | N/A | $285K-87.6% | $2.3M+8.7% | $2.1M+46.7% | $1.4M+47.8% | $978K+240.5% | $287K | N/A |
| Goodwill | N/A | N/A | N/A | $764.6M+9.3% | $699.7M+41.2% | $495.4M+51.7% | $326.5M | N/A | $206.1M |
| Total Liabilities | $815.5M+11.6% | $730.7M-10.0% | $812.3M+8.7% | $747.1M+20.8% | $618.4M+63.9% | $377.3M+89.8% | $198.7M+135.1% | $84.5M | N/A |
| Current Liabilities | $161.4M-12.5% | $184.4M-15.5% | $218.2M+27.3% | $171.3M+24.6% | $137.5M+21.2% | $113.5M+36.9% | $82.9M+76.5% | $47.0M | N/A |
| Non-Current Liabilities | $654.1M+19.7% | $546.4M-8.0% | $594.2M+3.2% | $575.8M+19.7% | $480.9M+82.3% | $263.8M+127.7% | $115.8M+208.4% | $37.6M | N/A |
| Long-Term Debt | $364.0M+22.9% | $296.2M-11.4% | $334.2M+1.7% | $328.7M+47.1% | $223.5M+127.5% | $98.3M+5750.6% | $1.7M-87.2% | $13.2M | N/A |
| Total Equity | $885.8M+28.3% | $690.5M-7.0% | $742.3M+22.7% | $605.2M+14.4% | $528.8M-1.3% | $535.7M+4.3% | $513.8M+297.2% | $129.4M+816.3% | $14.1M |
| Retained Earnings | $481.0M+47.9% | $325.3M+14.4% | $284.5M+49.6% | $190.1M+67.9% | $113.2M+44.2% | $78.6M+172.4% | $28.8M | N/A | N/A |
Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments.
AFYA Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $279.6M+20.7% | $231.7M+7.7% | $215.1M+34.7% | $159.6M+41.1% | $113.2M+58.2% | $71.5M-3.9% | $74.5M+259.7% | $20.7M+71.7% | $12.1M |
| Depreciation & Amortization | $68.2M+26.5% | $53.9M-9.7% | $59.7M+52.9% | $39.0M+41.0% | $27.7M+32.1% | $20.9M+15.0% | $18.2M+678.0% | $2.3M+92.6% | $1.2M |
| Capital Expenditures | $30.3M+36.9% | $22.1M-9.3% | $24.4M-23.3% | $31.8M+40.9% | $22.6M+30.5% | $17.3M+22.0% | $14.2M+195.2% | $4.8M-5.2% | $5.1M |
| Free Cash Flow | $249.3M+19.0% | $209.5M+9.9% | $190.7M+49.2% | $127.8M+41.1% | $90.6M+67.0% | $54.2M-10.0% | $60.3M+279.2% | $15.9M+127.5% | $7.0M |
| Investing Cash Flow | -$92.6Mn/m | -$176.5Mn/m | -$235.6Mn/m | -$111.9Mn/m | -$228.5Mn/m | -$200.8Mn/m | -$88.1Mn/m | -$67.6Mn/m | -$6.7M |
| Financing Cash Flow | -$147.6M-3908.2% | $3.9Mn/m | -$90.7M-615.7% | $17.6M-73.1% | $65.4M-55.1% | $145.6M-36.5% | $229.3M+306.5% | $56.4Mn/m | -$1.2M |
| Dividends Paid | $26.8M+806.4% | $3.0M-23.5% | $3.9M+3.5% | $3.7M+11.6% | $3.3M+33.8% | $2.5M-80.6% | $12.9M+755.9% | $1.5M+99.1% | $757K |
Not reported in any period shown, so not listed: Stock-Based Compensation, Share Buybacks.
AFYA Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.5%+1.2pp | 63.2%+1.8pp | 61.4%-1.7pp | 63.1%+1.0pp | 62.1%-1.7pp | 63.8%+5.0pp | 58.9%+9.2pp | 49.7%+7.1pp | 42.6% |
| Operating Margin | 32.8%+2.2pp | 30.6%+4.0pp | 26.7%-1.8pp | 28.5%+2.9pp | 25.6%-4.6pp | 30.3%+2.9pp | 27.3%-1.5pp | 28.9%+6.0pp | 22.8% |
| Net Margin | 20.3%+1.2pp | 19.1%+5.7pp | 13.4%-2.6pp | 16.0%+3.0pp | 13.0%-11.3pp | 24.3%+3.8pp | 20.5%-5.4pp | 25.9%+4.8pp | 21.0% |
| Return on Equity | 15.5%+0.7pp | 14.8%+4.1pp | 10.7%-0.9pp | 11.7%+4.1pp | 7.6%-2.9pp | 10.5%+3.0pp | 7.4%-9.7pp | 17.2%-79.9pp | 97.1% |
| Return on Assets | 8.0%+0.9pp | 7.1%+2.1pp | 5.1%-0.1pp | 5.2%+1.7pp | 3.5%-2.6pp | 6.1%+0.8pp | 5.3%-4.1pp | 9.4% | N/A |
| Current Ratio | 2.20+0.8x | 1.39+0.3x | 1.14-0.7x | 1.81+0.2x | 1.57-0.8x | 2.38-1.0x | 3.34+2.6x | 0.73 | N/A |
| Debt-to-Equity | 0.410.0x | 0.430.0x | 0.45-0.1x | 0.54+0.1x | 0.42+0.2x | 0.18+0.2x | 0.00-0.1x | 0.10 | N/A |
| Liabilities-to-Equity | 0.92-0.1x | 1.060.0x | 1.09-0.1x | 1.23+0.1x | 1.17+0.5x | 0.70+0.3x | 0.39-0.3x | 0.65 | N/A |
| Asset Turnover | 0.400.0x | 0.370.0x | 0.38+0.1x | 0.32+0.1x | 0.270.0x | 0.250.0x | 0.26-0.1x | 0.36 | N/A |
| FCF Margin | 36.9%-2.3pp | 39.2%+7.0pp | 32.2%+3.2pp | 29.0%-0.4pp | 29.4%+5.9pp | 23.4%-8.8pp | 32.3%+13.8pp | 18.5%+7.8pp | 10.7% |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Afya Limited AFYA | FY2025 | $675.1M | $137.4M | 20.3% | $899.8M | 74/100 |
| Universal Technical Institute, Inc. UTI | FY2025 | $835.6M | $63.0M | 7.5% | $1.3B | 61/100 |
| Coursera, Inc. COUR | FY2025 | $757.5M | -$51.0M | -6.7% | $1.2B | 54/100 |
| Youdao, Inc. DAO | FY2025 | $845.0M | $15.4M | 1.8% | $2.3B | 28/100 |
| Gaotu Techedu Inc. GOTU | FY2025 | $879.0M | -$46.2M | -5.3% | $533.6M | 47/100 |
Where Afya Limited Ranks
Frequently Asked Questions
What is Afya Limited's annual revenue?
Afya Limited (AFYA) reported $675.1M in total revenue for fiscal year 2025. This represents a 26.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Afya Limited's revenue growing?
Afya Limited (AFYA) revenue grew by 26.3% year-over-year, from $534.3M to $675.1M in fiscal year 2025.
Is Afya Limited profitable?
Yes, Afya Limited (AFYA) reported a net income of $137.4M in fiscal year 2025, with a net profit margin of 20.3%.
What is Afya Limited's EBITDA?
Afya Limited (AFYA) had EBITDA of $289.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Afya Limited have?
As of fiscal year 2025, Afya Limited (AFYA) had $205.5M in cash and equivalents against $364.0M in long-term debt.
What is Afya Limited's gross margin?
Afya Limited (AFYA) had a gross margin of 64.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Afya Limited's operating margin?
Afya Limited (AFYA) had an operating margin of 32.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Afya Limited's net profit margin?
Afya Limited (AFYA) had a net profit margin of 20.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Afya Limited's return on equity (ROE)?
Afya Limited (AFYA) has a return on equity of 15.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Afya Limited's free cash flow?
Afya Limited (AFYA) generated $249.3M in free cash flow during fiscal year 2025. This represents a 19.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Afya Limited's operating cash flow?
Afya Limited (AFYA) generated $279.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Afya Limited's total assets?
Afya Limited (AFYA) had $1.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Afya Limited's capital expenditures?
Afya Limited (AFYA) invested $30.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Afya Limited's current ratio?
Afya Limited (AFYA) had a current ratio of 2.20 as of fiscal year 2025, which is generally considered healthy.
What is Afya Limited's debt-to-equity ratio?
Afya Limited (AFYA) had a debt-to-equity ratio of 0.41 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Afya Limited's liabilities-to-equity ratio?
Afya Limited (AFYA) had a liabilities-to-equity ratio of 0.92 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Afya Limited's return on assets (ROA)?
Afya Limited (AFYA) had a return on assets of 8.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Afya Limited's P/E ratio?
Afya Limited (AFYA) trades at 6.5x earnings, its market capitalization divided by $137.4M net income, FY2025. The market capitalization is $899.8M as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Afya Limited's price-to-sales ratio?
Afya Limited (AFYA) trades at 1.3x sales, its market capitalization divided by $675.1M revenue, FY2025. The market capitalization is $899.8M as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Afya Limited's Altman Z-Score?
Afya Limited (AFYA) has an Altman Z-Score of 2.01, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Afya Limited's Piotroski F-Score?
Afya Limited (AFYA) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Afya Limited's earnings high quality?
Afya Limited (AFYA) has an earnings quality ratio of 2.04x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Afya Limited cover its interest payments?
Afya Limited (AFYA) has an interest coverage ratio of 2.16x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Afya Limited?
Afya Limited (AFYA) scores 74 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.